Key Takeaway: Travere Therapeutics will announce its third quarter 2026 financial results on November 2, 2026. The company plans to hold a conference call and webcast at 4:30 p.m. ET to discuss the results and provide a business update. Investors can access the information through the company's website.
Market Sentiment Analysis
POSITIVE FACTORS
Travere Therapeutics will report financial results soon.
The company is hosting a conference call for updates.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+24%
120-day peak, hindsight
Typical move
10.2%
average across 11 past catalysts
Lead asset
L-Citrulline
Phase 3 · Sickle Cell Disease
Full Press Release Details
SAN DIEGO--(BUSINESS WIRE)---- $TVTX--Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced it will report third quarter 2026 financial results on Monday, November 2, 2026, after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET.The webcast and dial-in information can be accessed on the Investor page of Travere’s website at https://ir.travere.com/events-and-presentations. F
Frequently Asked Questions
When will Travere report its Q3 2026 results?
Travere will report its Q3 2026 results on November 2, 2026.
What time is the conference call for Q3 results?
The conference call is scheduled for 4:30 p.m. ET.
Where can I access the conference call information?
Access the information on the Investor page of Travere's website.
What will be discussed during the conference call?
The call will cover financial results and a general business update.